Advertisement
News
Advertisement

MBL International Corporation Introduces AngioPhaseT Angiogenesis Kit

Thu, 02/09/2012 - 6:46am
The Associated Press

/FROM PR NEWSWIRE DALLAS 888-776-3971/

STK

IN HEA MTC BIO MEQ

SU PDT LIC

TO BUSINESS, HEALTH, AND MEDICAL EDITORS:

MBL International Corporation Introduces AngioPhaseT Angiogenesis Kit

WOBURN, Mass., Feb. 9, 2012 /PRNewswire/ -- MBL International

Corporation, a leading life science company focused on providing high

quality products and solutions for life science research and clinical

diagnostics, today announced the launch of AngioPhaseT, an

angiogenesis kit which allows for the analysis of all known phases of

the angiogenic process in a convenient and flexible format.

Angiogenesis is the multistep process whereby new blood vessels

develop from pre-existing vasculature. It plays a key role in the

natural process of healing and reproduction but also in many

pathological processes including cancer, skin diseases, age-related

blindness, diabetic ulcers, cardiovascular disease, and stroke.

AngioPhaseT incorporates a patented technology, developed by TCS

Cellworks Limited, Buckingham, UK, in which human endothelial cells

are co-cultured with other human cells in a specially designed medium.

Under the terms of the non-exclusive agreement with TCS Cellworks

Limited, MBL International Corporation has been granted a license to

manufacture and sell the assay in North and South America.

"MBL International is excited about adding AngioPhase to our growing

portfolio of life sciences products," said Dennis Walczewski, CEO MBL

International Corporation. "This technology offers many benefits to

researchers in the biotechnology and pharmaceutical industries by

offering a ready-to-use angiogenesis kit in which test compounds can

be added at any time. Moreover, both angiogenic simulators and

inhibitors can be assessed as well as tubule formation."

"We are pleased to enter into this licensing agreement with MBL

International Corporation," stated Tim Almond CEO of TCS Cellworks.

"They have demonstrated not only a strong commitment to manufacturing

high quality products but also an impressive business model which

leverages the superior technical expertise of their commercial team."

About MBL International Corporation

MBL International Corporation is a leading life science company

focused on providing high quality products and solutions for life

science research and clinical diagnostics. Our products are used

widely in academic research institutions, pharmaceutical and

biotechnology companies, government agencies, as well as hospital and

reference laboratories. By providing a consultative approach, superior

technical and customer support, and convenient purchasing options, MBL

International Corporation is your partner in solving your scientific

and clinical challenges.

For more information visit http://www.mblintl.com or call

800-200-5459.

About TCS Cellworks Limited

TCS Cellworks is a UK based cellular biology company specializing in

the development and application of human primary cell tissue models

for the bioscience and pharmaceutical business sectors. The success of

the AngioPhase kit in Europe is now being expanded to other markets

through carefully selected business partners. TCS also acts as a

distributor for a number of international manufacturers in the cell

biology field. For further information visit

http://www.tcscellworks.co.uk or call 0044 1280 827475.

SOURCE MBL International Corporation

-0- 02/09/2012

/CONTACT: Christopher Hargadon, +1-781-939-6964 ext 1107

/Web Site: http://www.mblintl.com

CO: MBL International Corporation; TCS Cellworks Limited

ST: Massachusetts United Kingdom

IN: HEA MTC BIO MEQ

SU: PDT LIC

PRN

-- NE50706 --

0000 02/09/2012 16:00:00 EDT http://www.prnewswire.com

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading